Q&A: Lung inflammation decreases with form of vitamin B3 in COPD
Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung inflammation, according to results published in Nature Aging.In a double-blind, randomized, placebo-controlled trial, Morten Scheibye-Knudsen, MD, PhD, associate professor at the Center for Healthy Aging in the department of cellular and molecular medicine at